Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$667,025
+$23,140 QoQ
Shares Held
1,842
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,986
of 3,140 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversified Enterprises, LLC holds $20,838,520 across 11 Drug Manufacturers - General names. AMGN ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,682 | $6,815,161 | |
| 2 | JNJ |
Johnson & Johnson
|
17,605 | $4,471,141 | |
| 3 | ABBV |
AbbVie Inc.
|
12,729 | $3,203,125 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,584 | $1,874,044 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
16,834 | $969,975 | |
| 6 | AZN |
Astrazeneca PLC
|
4,654 | $882,491 | |
| 7 | PFE |
Pfizer Inc
|
31,160 | $750,332 | |
| 8 | AMGN |
Amgen Inc
This page
|
1,842 | $667,025 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $667,025 | 1,842 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $643,885 | 1,830 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $605,523 | 1,850 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $220,680 | 782 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $226,997 | 813 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $418,100 | 1,342 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $262,464 | 1,007 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $288,700 | 896 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||